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METHODOLOGY Open Access
Understanding test accuracy research: a
test consequence graphic
Penny Whiting1,2* and Clare Davenport3
Abstract
Background: Presenting results of diagnostic test accuracy research so that it is accessible to users is challenging.
Commonly used accuracy measures (e.g. sensitivity and specificity) are poorly understood by health professionals
and the public. Evidence suggests that presenting probabilities as natural frequencies rather than percentages
facilitates understanding. We present a test consequence graphic to display results based on natural frequencies
and test consequences.
Methods: The graphic was developed as part of a project to develop guidance for writing plain language summaries
for Cochrane diagnostic test accuracy (DTA) reviews. Using a mixed methods approach (focus groups, user testing,
web-based surveys, public engagement and piloting), the graphic emerged as a clear preference out of a range of
methods for presenting probabilistic information (text only, numbers embedded in text, annotated graphic) across
patient representatives, media representatives and health professionals. The structure of the graphic was refined during
the research process.
Results: The test consequence graphic displays the results of diagnostic test accuracy study or review as natural
frequencies based on a hypothetical cohort of 1000 patients receiving the test.
Conclusions: The test consequence graphic provides a tool to help researchers communicate the results of diagnostic
research in a simple, easy to access format and encourage meaningful application of research findings to practice. Key
to this is linking estimates of test accuracy to potential downstream consequences of testing.
Keywords: Diagnosis, Natural frequencies, Graphical display
Background
Explaining the results of test accuracy research in plain
language is challenging. Outcome measures such as sensi-
tivity and specificity are less familiar and more poorly
understood than outcome measures used in intervention
studies (e.g. relative risk) [1]. The two-dimensional nature
of the measure of a test’s accuracy (the accuracy of a posi-
tive test result separate to the accuracy of a negative test
result) introduces further complexity.
Research suggests that natural frequencies may facili-
tate understanding of probabilistic information and bet-
ter estimation of the post-test probability of disease [1,
2]. In addition, simultaneous presentation of probabilis-
tic information using textual explanation and numeric
and graphic formats are preferred over the use of any of
these presentation formats alone [3–6]. These findings
have important implications for how the results of test
accuracy research should be presented.
In this article, we introduce a graphic (the “test conse-
quence graphic”) to present the results of test accuracy
research, both primary studies and systematic reviews.
The graphic is based on a natural frequency representa-
tion of the results that would be expected if the test
under evaluation were applied to a hypothetical cohort
of patients suspected of having the disease (target condi-
tion) for which the test is being used. It also incorpo-
rates the implications of each potential test result.
Methods
Development of the figure
The graphic presented here was developed as part of a
project to develop guidance for writing plain language
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summaries for Cochrane diagnostic test accuracy (DTA)
reviews. We have previously used similar graphics to
present the results of work based on diagnosing urinary
tract infection and myocardial infarction; however, these
did not incorporate test consequences [7, 8].
We used a mixed methods approach consisting of
focus groups, user testing, web-based surveys and a pub-
lic engagement event to develop the test consequence
graphic. Initial focus groups were conducted with a
range of potential end-users including one with con-
sumers (eight participants), one with journalists (nine
participants) and one with clinicians (two participants).
During the focus groups, we suggested a range of pos-
sible methods of presenting the numerical results of a
systematic review including (1) text description based on
sensitivity/specificity, (2) text description based on nat-
ural frequencies, (3) bulleted text description based on
natural frequencies, (4) natural frequency graphic based
on a hypothetical cohort of 1000 patients and (5) text-
only description with no numbers (Additional file 1:
Web Appendix A). The graphical display emerged as a
clear preference across all three focus groups and was
therefore adopted as the method that should be used to
summarise the numerical results. Based on suggestions
from the focus group, we restructured the graphic to
flow from left to right rather than top to bottom and
replaced the colours with different shaped boxes as there
was concern that colours could be difficult to interpret
for people who are colour blind. We also added
additional boxes showing the consequences of each
potential test result (true positive, false positive, true
negative and false negative).
The next stage of the development process involved
one-on-one user testing with potential stake holders—four
clinicians, one journalist, one commissioner, one
Cochrane review author and one patient representative
(Additional file 1: Web Appendix B). All supported the
changes and no further changes were suggested. We then
moved to a web-based survey to gain feedback from a
wider group of participants. This was completed by 67 re-
spondents including media representatives, methodolo-
gists, systematic review authors, health professionals and
patient representatives. There was strong support for the
use of a figure to summarise results and in particular the
inclusion of information about consequences, although it
was suggested that “implications” might be a more appro-
priate heading. Other changes made based on the survey
included adding the colours back to the boxes—although
the concerns regarding people with colour blindness were
acknowledged, respondents felt that having the different
shaped boxes would address these concerns and that
colours in addition to this would be helpful for others. A
refined version was produced that was considered as part
of the second round of the survey (Additional file 1: Web
Appendix C); no further changes were needed. The same
version was used for a public engagement event where we
presented the example plain language summary and figure
to a group of 16- to 18-year-old school students. They
suggested that the colours could be improved on the dia-
gram by using less bright colours. They also felt that it
was important to supplement the diagram with a text
summary of results. This was added and has resulted in
the final version (Fig. 1). This has been shared for further
feedback during workshops at Cochrane Colloquia and
with Cochrane DTA Editors. All have been positive about
the diagram and no further changes have been suggested.
Results
Producing the figure
Structure
The diagram shows the consequences of using the index
test (test under evaluation) in a hypothetical population
of 1000 patients suspected of having the condition of
interest (the target condition). Numerical information is
presented in a natural frequency format. The size of the
hypothetical cohort may be increased where the preva-
lence of the target condition is very low as research sug-
gests that understanding is compromised when numbers
being handled are very small [9, 10].
Data required
In order to populate the figure with natural frequencies,
estimates of the accuracy of the index test (sensitivity
and specificity) and prevalence of the target condition
are needed. Sensitivity and specificity estimates may be
derived from a single test accuracy study or from the
meta-analysis of a DTA review. Where more than one
estimate of sensitivity and specificity is available, the
choice of which estimates to present will be influenced
by factors such as precision and quality (the validity and
applicability to the particular testing context being pre-
sented in the figure).
Estimating the prevalence of the target condition is a
key first step in producing the graphic and will have im-
plications for the applicability of the diagram. Estimates
of the prevalence of the target condition can be derived
from a number of sources. In a primary DTA study, an
estimate of the prevalence of the target condition is ob-
tained by dividing the number of individuals with the
target condition by the total number tested. In a DTA
review, the median prevalence, a pooled estimate of
prevalence across all included studies or a prevalence
estimate based on only higher quality (valid and applic-
able) studies, could be used. Other sources of prevalence
data include disease registries, routine data sources,
audits, epidemiological studies or professional opinion.
Table 1 illustrates how natural frequencies are derived
from estimates of sensitivity, specificity and prevalence.
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Figure 1 shows how to use the information from Table 1
to construct the diagram.
Our research to develop the diagram suggested that
accompanying the diagram with a text description of
results helps understanding. We suggest the following
example of text that may be used:
“The results of this study/these studies indicate that in
theory, if the [index test] were to be used in [setting] in
a group of 1000 people where [x# (x%)] have [target
condition] then:
 An estimated [TP + FP] will have an [index test]
result indicating [target condition] and of these
[FP(FP/{TP + FP} × 100%)] will not have [target
condition]
 Of the [TN + FN] people with a result indicating
that [target condition] is not present, [FN(FN/(TN
+ FN} × 100%)] will actually have [target condition]”
We illustrate the process of generating the graphic and
accompanying textual explanation using the results of a
DTA review of rapid tests for diagnosing group A
streptococcus in children with sore throat [11]. This
review reported a summary sensitivity of 85.7%, a sum-
mary specificity of 95.4% and the median prevalence of
strep A infection across included studies was 30%.
Using Table 1 introduced above, we can obtain natural
frequency estimates of the numbers of true positive
(TP), false positive (FP), false negative (FN) and true
negative (TN) test results that would be obtained if the
rapid strep A test were applied to a hypothetical cohort
of 1000 children in whom the prevalence of strep A
infection was 30% (see Table 2).
Figure 2 illustrates the graphic for the strep A example
populated using natural frequencies from Table 2 and
annotated with the potential downstream consequences
of testing. The suggested accompanying text would read:
Fig. 1 Template for development of example figure
Table 1 Calculating natural frequencies from estimates of sensitivity, specificity and prevalence
Target condition present Target condition absent Total
Test positive TP = x × sens FP = y − (y × spec) TP + FP
Test negative FN = x − (x × sens) TN = y × spec FN + TN
x = 1000 × p y = 1000 − (1000 × p) 1000
Sens sensitivity, spec specificity, p prevalence, TN true negative—test is negative and patient does not have target condition, FN false negative—test is negative
but patient has target condition, TP true positive—test is positive and patient has target condition, FP false positive—test is positive but patient does not have
target condition, x number of patients with target condition, y number of patients without target condition
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“The results of these studies indicate that in theory, if
rapid tests were to be used in a group of 1000 children
with sore throats, of which 300 (30%) are actually caused
by bacterial infection then:
 An estimated 289 will have a rapid test result
indicating that their sore throat is caused by a
bacterial infection and of these 32 (11%) will not
have a bacterial infection
 Of the 711 children with a rapid test result
indicating that they do not have a bacterial
infection, 43 (6%) will actually have one”
Additional considerations
We suggest only including one flow diagram to summar-
ise the main results to facilitate understanding and to
draw attention to the most important findings from a
piece of test accuracy research. Scenarios where multiple
estimates of accuracy and/or prevalence may be present
include:
 Presence of multiple estimates of accuracy for a
single test (for example at different test positivity
thresholds, in different patient groups, as a result of
variation in quality of included studies in a
systematic review)
 Presence of estimates of accuracy for more than one
index test
A priori selection of primary analysis in test accuracy
research may support the process of selection but are
rarely sufficient to solve it completely. The most appro-
priate approach will vary across studies and will require
clinical and methodological expertise.
The presence of variation in estimates of accuracy
aside from that presented in the flow diagram should be
highlighted in accompanying text, although the level of
detail presented will be restricted by the need for plain
language. Depending on the method of publication and
dissemination, additional information may be made
available as appendices or supplementary figures. Avail-
ability online offers the potential to make the figure
Table 2 Natural frequency estimates based on the summary sensitivity and specificity and median prevalence of strep A infection
from the systematic review of rapid tests for diagnosing group A streptococcus in children with sore throats
Disease present Disease absent Total
Test positive 300 × 0.857 = 257 700 − (700 × 0.954) = 32 TP + FP = 289
Test negative 300 − (300 × 0.857) = 43 700 × 0.954 = 668 FN + TN = 711
1000 × 0.3 = 300 1000 − 300 = 700 1000
Fig. 2 Figure showing results that would be obtained if a hypothetical cohort of 1000 children were tested for strep A infection using rapid tests
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interactive so that different estimates of prevalence, sen-
sitivity and specificity can be selected with the numbers
included in the diagram automatically updating.
Discussion
We consider that the main strength of our proposed fig-
ure is that it will help researchers communicate the results
of diagnostic research in a simple, easy to access format
and encourage meaningful application of research findings
to practice. Key to this is linking estimates of test accuracy
to potential downstream consequences of testing. In
addition, greater consistency in the use of terminology
and presentation format should assist with the familiarisa-
tion of test accuracy research.
A limitation is the need to select single estimates of
prevalence, sensitivity and specificity. Natural frequency
representation of patient outcomes of testing in the figure
will only apply for the estimate of prevalence, sensitivity
and specificity used in the figure. If the prevalence given
in the figure is different to the estimate of prevalence that
a reader is interested in, then the numbers will not be ap-
plicable. It is also not possible to convey uncertainty
around estimates of accuracy in the figure. It is therefore
important to stress the setting specific nature of test ac-
curacy estimates to users of the graphic. One potential
method of overcoming these limitations would be to make
an interactive version of the figure available online so that
different estimates of prevalence, sensitivity and specificity
can be selected with the numbers included in the diagram
automatically updating.
Conclusions
The test consequence graphic provides a tool to help
researchers communicate the results of diagnostic
research in a simple, easy to access format and encour-
age meaningful application of research findings to prac-
tice. Linking estimates of test accuracy to potential
downstream consequences of testing is a key feature of
the proposed graphic.
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